BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38324631)

  • 1. BRCA-associated protein1 (BAP1) immunohistochemical stain reliability in postbrachytherapy uveal melanoma enucleation specimens.
    Eiger-Moscovich M; Shields CL; Eagle RC; Milman T
    Indian J Ophthalmol; 2024 May; 72(Suppl 3):S459-S467. PubMed ID: 38324631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of BAP1 protein expression provide insights into prognostic significance and the biology of uveal melanoma.
    Farquhar N; Thornton S; Coupland SE; Coulson JM; Sacco JJ; Krishna Y; Heimann H; Taktak A; Cebulla CM; Abdel-Rahman MH; Kalirai H
    J Pathol Clin Res; 2018 Jan; 4(1):26-38. PubMed ID: 29416875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Piloting a Deep Learning Model for Predicting Nuclear BAP1 Immunohistochemical Expression of Uveal Melanoma from Hematoxylin-and-Eosin Sections.
    Zhang H; Kalirai H; Acha-Sagredo A; Yang X; Zheng Y; Coupland SE
    Transl Vis Sci Technol; 2020 Sep; 9(2):50. PubMed ID: 32953248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between BAP1 Localization, Driver Mutations, and Patient Survival in Uveal Melanoma.
    Cole YC; Zhang YZ; Gallo B; Januszewski AP; Nastase A; Essex DJ; Thaung CMH; Cohen VML; Sagoo MS; Bowcock AM
    Cancers (Basel); 2022 Aug; 14(17):. PubMed ID: 36077643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Value of BAP1 Protein Expression in Uveal Melanoma.
    Kennedy S; Owens S; Ivers L; Hegarty C; O'Neill V; Berenguer-Pina JJ; Horgan N; Crown J; Walsh N
    Am J Surg Pathol; 2024 Mar; 48(3):329-336. PubMed ID: 38238977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BAP1 Immunostain Status in Intraocular Biopsy Specimens for Uveal Melanoma Highly Correlates with Other Prognostic Markers.
    Ida CM; Pulido J; Greipp PT; Garcia JJ; Olsen TW; Dalvin L; Salomão DR
    Ocul Oncol Pathol; 2022 Feb; 8(1):22-29. PubMed ID: 35356602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosome 3 status combined with BAP1 and EIF1AX mutation profiles are associated with metastasis in uveal melanoma.
    Ewens KG; Kanetsky PA; Richards-Yutz J; Purrazzella J; Shields CL; Ganguly T; Ganguly A
    Invest Ophthalmol Vis Sci; 2014 Jun; 55(8):5160-7. PubMed ID: 24970262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BAP1 Immunoreactivity Correlates with Gene Expression Class in Uveal Melanoma.
    See TR; Stålhammar G; Phillips S; Grossniklaus HE
    Ocul Oncol Pathol; 2020 Mar; 6(2):129-137. PubMed ID: 32258021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of BAP1 protein expression in uveal melanoma is associated with increased metastatic risk and has utility in routine prognostic testing.
    Kalirai H; Dodson A; Faqir S; Damato BE; Coupland SE
    Br J Cancer; 2014 Sep; 111(7):1373-80. PubMed ID: 25058347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular Lakes in Uveal Melanoma and Their Association With Outcome.
    Jones H; Kalirai H; Taktak A; Chen K; Coupland SE
    Transl Vis Sci Technol; 2022 Mar; 11(3):32. PubMed ID: 35348598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of chromosomal imbalances, gene mutations, and BAP1 expression in uveal melanoma.
    Patrone S; Maric I; Rutigliani M; Lanza F; Puntoni M; Banelli B; Rancati S; Angelini G; Amaro A; Ligorio P; Defferrari C; Castagnetta M; Bandelloni R; Mosci C; DeCensi A; Romani M; Pfeffer U; Viaggi S; Coviello DA
    Genes Chromosomes Cancer; 2018 Aug; 57(8):387-400. PubMed ID: 29689622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Germline versus Somatic BAP1 Mutations for Risk of Metastasis in Uveal Melanoma.
    Ewens KG; Lalonde E; Richards-Yutz J; Shields CL; Ganguly A
    BMC Cancer; 2018 Nov; 18(1):1172. PubMed ID: 30477459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uveal Melanoma Nuclear BRCA1-Associated Protein-1 Immunoreactivity Is an Indicator of Metastasis.
    Szalai E; Wells JR; Ward L; Grossniklaus HE
    Ophthalmology; 2018 Feb; 125(2):203-209. PubMed ID: 28823399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Factor Utility of BAP1 Immunohistochemistry in Uveal Melanoma: A Single Center Study in Spain.
    Tabuenca Del Barrio L; Nova-Camacho LM; Zubicoa Enériz A; Martínez de Espronceda Ezquerro I; Córdoba Iturriagagoitia A; Borque Rodríguez-Maimón E; García-Layana A
    Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic impact of chromosomal aberrations and GNAQ, GNA11 and BAP1 mutations in uveal melanoma.
    Staby KM; Gravdal K; Mørk SJ; Heegaard S; Vintermyr OK; Krohn J
    Acta Ophthalmol; 2018 Feb; 96(1):31-38. PubMed ID: 28444874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour Angiogenesis in Uveal Melanoma Is Related to Genetic Evolution.
    Brouwer NJ; Gezgin G; Wierenga APA; Bronkhorst IHG; Marinkovic M; Luyten GPM; Versluis M; Kroes WGM; van der Velden PA; Verdijk RM; Jager MJ
    Cancers (Basel); 2019 Jul; 11(7):. PubMed ID: 31337000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Value of BAP1 and Preferentially Expressed Antigen in Melanoma (PRAME) Immunohistochemistry in Uveal Melanomas.
    Han LM; Lee KW; Uludag G; Seider MI; Afshar AR; Bloomer MM; Pekmezci M
    Mod Pathol; 2023 Apr; 36(4):100081. PubMed ID: 36788079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BAP1 germline mutation in two first grade family members with uveal melanoma.
    Maerker DA; Zeschnigk M; Nelles J; Lohmann DR; Worm K; Bosserhoff AK; Krupar R; Jägle H
    Br J Ophthalmol; 2014 Feb; 98(2):224-7. PubMed ID: 24187051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective analysis of secondary enucleation for uveal melanoma after plaque radiotherapy.
    Wang H; Zhang R; Wang Y; Chen R; Liu Y; Li Y; Wei W
    BMC Ophthalmol; 2022 Apr; 22(1):163. PubMed ID: 35397506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic utility of immunohistochemistry in concordance with mRNA analysis of PRAME in the stratification of high-risk uveal melanoma patients.
    Kumar N; Singh MK; Singh L; Lomi N; Meel R; Pushker N; Sen S; Kashyap S
    Hum Cell; 2023 Jan; 36(1):342-352. PubMed ID: 36282437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.